Experiences with
Jaypirca2 public posts
YABTKi or Yet Another BTK inhibitor - an A to Z list of Bruton's Tyrosine Kinase Inhibitors and Degraders following ibrutinib's success
Pirtobrutinib (Jaypirca) /LOXO-305 (non-covalent) (First Non-covalent approved)
https://cllsociety.org/2023/12/pirtobrutinib-is-the-first-reversible-btki-approved-in-cll-sll/
Works on patients with acquired resistance to available BTKis and Venetoclax Starting at the 50 mg QD dose, Pirtobrutinib
Want to take advantage of all our features? Just log in!
or